These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1341993)

  • 41. Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli.
    Fantin B; Ebert S; Leggett J; Vogelman B; Craig WA
    J Antimicrob Chemother; 1991 Jun; 27(6):829-36. PubMed ID: 1938689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Postantibiotic effects of telavancin against 16 gram-positive organisms.
    Pankuch GA; Appelbaum PC
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1275-7. PubMed ID: 19124659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacodynamic effects of meropenem on gram-negative bacteria.
    Hanberger H; Svensson E; Nilsson LE; Nilsson M
    Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):383-90. PubMed ID: 7556226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postantibiotic effect of the penem FCE 22101 against selected gram-positive and gram-negative bacteria in vitro and in vivo by the use of a tissue cage model in rabbits.
    Bergholm AM; Dornbusch K
    APMIS; 1990 Mar; 98(3):269-75. PubMed ID: 2317348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of the Malthus Microbial Growth Analyser to study the post antibiotic effect of antibiotics.
    Gould IM; Jason AC; Milne K
    J Antimicrob Chemother; 1989 Oct; 24(4):523-31. PubMed ID: 2515188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In-vitro postantibiotic effects of miocamycin and erythromycin on gram-positive cocci.
    Varotto F; Garlaschi ML; Garlaschi MC; Falchi M; Scaglione F; Cattaneo G; De Luca M; Fraschini F
    J Chemother; 1990 Dec; 2(6):355-61. PubMed ID: 2093106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergic post-antibiotic effect of mecillinam, in combination with other beta-lactam antibiotics in relation to morphology and initial killing.
    Hanberger H; Nilsson LE; Svensson E; Maller R
    J Antimicrob Chemother; 1991 Oct; 28(4):523-32. PubMed ID: 1761447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy.
    Periti P
    J Chemother; 1995 Aug; 7(4):311-37. PubMed ID: 8568543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postantibiotic effect of beta-lactam antibiotics on Escherichia coli evaluated by bioluminescence assay of bacterial ATP.
    Hanberger H; Nilsson LE; Kihlström E; Maller R
    Antimicrob Agents Chemother; 1990 Jan; 34(1):102-6. PubMed ID: 2183707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of plant derivatives on the growth of foodborne pathogens and the functionality of probiotics.
    Gyawali R; Ibrahim SA
    Appl Microbiol Biotechnol; 2012 Jul; 95(1):29-45. PubMed ID: 22622837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacodynamic effects of subinhibitory antibiotic concentrations.
    Odenholt I
    Int J Antimicrob Agents; 2001 Jan; 17(1):1-8. PubMed ID: 11137642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
    Burgess DS
    Chest; 1999 Mar; 115(3 Suppl):19S-23S. PubMed ID: 10084455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A clinical study on postantibiotic effect (PAE) and its application to chemotherapy for complicated cystitis with an automatic simulator of urinary drug concentration].
    Nishimura M; Kumamoto Y; Hirose T; Shibuya A; Tsukamoto T; Ohya S
    Kansenshogaku Zasshi; 1992 Feb; 66(2):135-43. PubMed ID: 1402073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a method to quantify in vitro the synergistic activity of "natural" antimicrobials.
    Dufour M; Simmonds RS; Bremer PJ
    Int J Food Microbiol; 2003 Aug; 85(3):249-58. PubMed ID: 12878383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of infections caused by gram-negative bacilli: the role of antimicrobial combinations.
    Allan JD; Moellering RC
    Rev Infect Dis; 1985; 7 Suppl 4():S559-71. PubMed ID: 3909313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inoculum-Based Dosing: A Novel Concept for Combining Time with Concentration-Dependent Antibiotics to Optimize Clinical and Microbiological Outcomes in Severe Gram Negative Sepsis.
    Tilanus A; Drusano G
    Antibiotics (Basel); 2023 Oct; 12(11):. PubMed ID: 37998783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modeling the mechanism of postantibiotic effect and determining implications for dosing regimens.
    Geli P
    J Math Biol; 2009 Nov; 59(5):717-28. PubMed ID: 19189107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kinetics of antimicrobial activity.
    Vogelman B; Craig WA
    J Pediatr; 1986 May; 108(5 Pt 2):835-40. PubMed ID: 3701535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characteristics and dynamics of bacterial populations during postantibiotic effect determined by flow cytometry.
    Gottfredsson M; Erlendsdóttir H; Sigfússon A; Gudmundsson S
    Antimicrob Agents Chemother; 1998 May; 42(5):1005-11. PubMed ID: 9593117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of substrate limitation and growth phase on sensitivity to antimicrobial agents.
    Brown MR; Williams P
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():7-14. PubMed ID: 3980338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.